Graphic from the poster showing the evolution of guidelines in the 20 countries (www.aidsmap.com)
Although dolutegravir has been recommended by the World Health Organization (WHO) as part of first-line HIV treatment for all adults since 2019, less than half of the African countries with the highest burden of HIV follow these guidelines, according to an analysis presented to the 11th International AIDS Conference on HIV Science today.
With its high barrier to resistance, virological potency, superior side-effects profile and lower cost, the integrase inhibitor dolutegravir represents an improvement on previously recommended medications. Its first regulatory approval was in 2013, and in 2016 WHO recommended it as part of an alternate first line regimen.
However, preliminary data on a possible raised risk of neural tube defects from a study in Botswana in May 2018 led to safety warnings from international regulatory agencies. That summer WHO recommended dolutegravir for women of childbearing age only if reliable contraception were available. Roll-out of dolutegravir in many countries slowed or reversed.
Glossary
stigma
Social attitudes that suggest that having a particular illness or being in a particular situation is something to be ashamed of. Stigma can be questioned and challenged.
integrase inhibitors (INI, INSTI)
A class of antiretroviral drugs. Integrase strand transfer inhibitors (INSTIs) block integrase, which is an HIV enzyme that the virus uses to insert its genetic material into a cell that it has infected. Blocking integrase prevents HIV from replicating.
Follow-up data from the Botswana cohort and elsewhere has tempered concerns about dolutegravir’s safety in pregnancy. In July 2019, WHO reversed itself and recommended dolutegravir as part of the preferred first-line HIV treatment for all adults, including women of childbearing age. However the concerns and hesitancy appear to have had long-lasting effects.
Somya Gupta and Dr Reuben Granich examined treatment guidelines published by the 20 sub-Saharan African countries with the greatest burden of HIV (covering 94% of people with HIV in the region). As of this month:
- Eight of the 20 countries recommend dolutegravir for all adults, in line with the current (2019) WHO guidelines. These countries are Botswana, Eswatini, Rwanda, South Africa, Tanzania, Uganda, Zambia and Zimbabwe, covering around 55% of people living with HIV in Africa.
- Five countries recommend dolutegravir – except for pregnant women – which is in keeping with the superseded 2018 WHO guidelines. Between them, Côte d’Ivoire, Ethiopia, Kenya, Malawi and Namibia have 15% of HIV-positive people in the region.
- Two countries only recommend the drug as an alternate regimen, in line with the 2016 WHO guidelines: Lesotho and Nigeria, with 9% of people with HIV.
- Five countries do not recommend dolutegravir at all: Angola, Cameroon, Democratic Republic of Congo, Mozambique and South Sudan. Fifteen per cent of HIV-positive African people are in these countries.
In countries which have adopted the 2019 recommendations, the average time lag between international and national guidelines was five months. If all the other countries updated their guidelines today, the average time lag would be 15 months.
“The 2018 WHO false alarm and ensuing confused messaging about safety stigmatised dolutegravir and may have contributed to the ongoing delay in adoption of dolutegravir in Sub-Saharan Africa,” conclude Gupta and Granich. They call for speedier processes to translate scientific knowledge into policy and services.
References
Gupta S & Granich R. HIV treatment in sub-Saharan Africa: delays in transition to dolutegravir. 11th IAS Conference on HIV Science, abstract PED507, 2021.
Newer articles:
- South Sudan: Shelter Cluster Factsheet, Q2 - 2021 - 19/07/2021 11:51
- South Sudan stops COVID-19 vaccination after exhausting vaccines - 19/07/2021 07:03
- South Sudan's civil servants find it hard to feed their families as food prices soar - 19/07/2021 04:55
- Divisions could deter Sudan’s democratic path - 19/07/2021 01:19
- Uganda: Elegu Border Officials Struggle to Control South Sudanese Seeking Food - 19/07/2021 01:10
Older news items
- Two Ugandan truck drivers shot dead in South Sudan - 17/07/2021 23:00
- South Sudanese Man Runs for Refugee Olympic Team - 17/07/2021 22:56
- Ethiopian war resumes, and this time, even children are not spared - 17/07/2021 01:22
- Turkey donates seeds, agricultural tools to South Sudan - 17/07/2021 01:08
- Plan afoot to remove President Kiir from power, declares former general - 16/07/2021 23:51
Latest news items (all categories):
- UAE company agreed to loan $13B to South Sudan in exchange for oil - 27/04/2024 16:44
- South Sudan auditor flags spending of IMF funds - 27/04/2024 16:41
- UN Aid Trucks Held up at South Sudan Border - 27/04/2024 16:37
- South Sudanese comedians find laughs in painful past - 27/04/2024 16:34
- The DRC had the world's biggest military spend increase last year – and South Sudan was second - 27/04/2024 16:29
Random articles (all categories):
- South Sudan: Key Peace Deal Deadline Passes - 12/08/2014 10:35
- Women car washers at UNMISS hope to become entrepreneurs in a peaceful South Sudan - 26/10/2020 04:01
- South Sudan ‘suffering a man-made’ tragedy - 20/02/2017 10:30
- S. Sudan: UN reaches 100,000 flood-affected victims - 27/10/2013 05:39
- South Sudan launches action plan for health care system - 10/12/2020 23:37
Popular articles:
- Who is the darkest person in the world, according to Guinness World Record? - 25/10/2022 02:34 - Read 32481 times
- No oil in troubled waters - 25/03/2014 15:02 - Read 21863 times
- School exam results in South Sudan show decline - 01/04/2012 17:58 - Read 20746 times
- NDSU student from South Sudan receives scholarship - In-Forum - 29/09/2012 01:44 - Read 17314 times
- With prisons full, South Sudan to introduce mobile courts to clear backlog of cases - 11/10/2012 11:29 - Read 14214 times